OBJECTIVE: Hepatic overexpression of sulfatase-2 (SULF2), a heparan sulfate remodeling enzyme, strongly contributes to high triglyceride (TG) levels in obese, type 2 diabetic (T2DM) db/db mice. Nevertheless, data in humans are lacking. Here, the association of human hepatic SULF2 expression and SULF2 gene variants with TG metabolism in patients with obesity and/or T2DM was investigated. METHODS: Liver biopsies from 121 obese subjects were analyzed for relations between hepatic SULF2 mRNA levels and plasma TG. Associations between seven SULF2 tagSNPs and TG levels were assessed in 210 obese T2DM subjects with dyslipidemia. Replication of positive findings was performed in 1,316 independent obese T2DM patients. Postprandial TRL clearance was evaluated in 29 obese T2DM subjects stratified by SULF2 genotype. RESULTS: Liver SULF2 expression was significantly associated with fasting plasma TG (r = 0.271; P = 0.003) in obese subjects. The SULF2 rs2281279(A>G) SNP was reproducibly associated with lower fasting plasma TG levels in obese T2DM subjects (P < 0.05). Carriership of the minor G allele was associated with lower levels of postprandial plasma TG (P < 0.05) and retinyl esters levels (P < 0.001). CONCLUSIONS: These findings implicate SULF2 as potential therapeutic target in the atherogenic dyslipidemia of obesity and T2DM.
OBJECTIVE: Hepatic overexpression of sulfatase-2 (SULF2), a heparan sulfate remodeling enzyme, strongly contributes to high triglyceride (TG) levels in obese, type 2 diabetic (T2DM) db/db mice. Nevertheless, data in humans are lacking. Here, the association of human hepatic SULF2 expression and SULF2 gene variants with TG metabolism in patients with obesity and/or T2DM was investigated. METHODS: Liver biopsies from 121 obese subjects were analyzed for relations between hepatic SULF2 mRNA levels and plasma TG. Associations between seven SULF2 tagSNPs and TG levels were assessed in 210 obese T2DM subjects with dyslipidemia. Replication of positive findings was performed in 1,316 independent obese T2DM patients. Postprandial TRL clearance was evaluated in 29 obese T2DM subjects stratified by SULF2 genotype. RESULTS: Liver SULF2 expression was significantly associated with fasting plasma TG (r = 0.271; P = 0.003) in obese subjects. The SULF2rs2281279(A>G) SNP was reproducibly associated with lower fasting plasma TG levels in obese T2DM subjects (P < 0.05). Carriership of the minor G allele was associated with lower levels of postprandial plasma TG (P < 0.05) and retinyl esters levels (P < 0.001). CONCLUSIONS: These findings implicate SULF2 as potential therapeutic target in the atherogenic dyslipidemia of obesity and T2DM.
Authors: J S Cohn; E J Johnson; J S Millar; S D Cohn; R W Milne; Y L Marcel; R M Russell; E J Schaefer Journal: J Lipid Res Date: 1993-12 Impact factor: 5.922
Authors: Hans L Mooij; Sophie J Bernelot Moens; Philip L S M Gordts; Kristin I Stanford; Erin M Foley; Marjolein A W van den Boogert; Julia J Witjes; H Carlijne Hassing; Michael W Tanck; Michiel A J van de Sande; J Han Levels; John J P Kastelein; Erik S G Stroes; Geesje M Dallinga-Thie; Jeff D Esko; Max Nieuwdorp Journal: J Lipid Res Date: 2015-01-07 Impact factor: 5.922
Authors: Tae Hyo Kim; Bubu A Banini; Faizal Z Asumda; Nellie A Campbell; Chunling Hu; Catherine D Moser; Abdirashid M Shire; Shaoshan Han; Chenchao Ma; Anuradha Krishnan; Taofic Mounajjed; Thomas A White; Gregory J Gores; Nathan K LeBrasseur; Michael R Charlton; Lewis Rowland Roberts Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-07-20 Impact factor: 4.052
Authors: Ferdous Anower-E-Khuda; Gagandeep Singh; Yiping Deng; Philip L S M Gordts; Jeffrey D Esko Journal: Glycobiology Date: 2019-07-19 Impact factor: 4.313
Authors: Amber Awa van der Heijden; Simone P Rauh; Jacqueline M Dekker; Joline W Beulens; Petra Elders; Leen M 't Hart; Femke Rutters; Nienke van Leeuwen; Giel Nijpels Journal: BMJ Open Date: 2017-06-06 Impact factor: 2.692
Authors: Marchien G Dallinga; Yasmin I Habani; Alinda W M Schimmel; Geesje M Dallinga-Thie; Cornelis J F van Noorden; Ingeborg Klaassen; Reinier O Schlingemann Journal: Cells Date: 2021-04-16 Impact factor: 6.600